125 filings
Page 3 of 7
8-K/A
hlmg6s00vx
11 Dec 20
Financial Statements and Exhibits
5:01pm
8-K
kk3masb04k bp094
11 Dec 20
Entry into a Material Definitive Agreement
8:28am
8-K
etk6uj yi
12 Nov 20
Salarius Pharmaceuticals Reports Business Highlights and Third Quarter 2020 Financial Results
8:01am
8-K
aia4ziu17gs4jekguvz
6 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
ibeyo0ke6 ek
12 Aug 20
Salarius Pharmaceuticals Reports Business Highlights and Second Quarter 2020 Financial Results
4:10pm
8-K
2rhx0dcf9xxx
3 Aug 20
Salarius Announces Pricing of $5.3 Million Underwritten Public Offering
4:29pm
8-K
8tqg q022fjgzfilbvpp
29 Jul 20
Salarius Announces Proposed Public Offering of Common Stock
4:34pm
8-K
uxty82dgorz9
19 Jun 20
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
84m7bbv c8i
18 Jun 20
Other Events
4:34pm
8-K
yge l33543a7g2
14 May 20
Salarius Pharmaceuticals Reports First Quarter 2020 Financial Results
4:09pm
8-K
xaoh894ozu9ghw
29 Apr 20
Departure of Directors or Certain Officers
4:31pm
8-K
03cvjw9b
10 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:14pm
8-K
jb8vlh8uwo s46an
27 Mar 20
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
4:35pm
8-K
ao6w 5xjrz9unl8es2
11 Mar 20
Other Events
4:28pm
8-K
s7torkm668jjc
12 Feb 20
Salarius Announces Pricing of $9.6 Million Underwritten Public Offering
5:14pm
8-K
8lrofi kkxg2
28 Oct 19
Salarius Pharmaceuticals and Aspire Capital Announce a $10.9M Common Stock Purchase Agreement
8:01am
8-K
rgg5kfluzpd
22 Oct 19
Submission of Matters to a Vote of Security Holders
4:22pm
8-K/A
gdm44aoxpiw9pgp1
18 Sep 19
Index to Financial Statements
4:55pm
8-K
kuakt
16 Sep 19
Departure of Directors or Certain Officers
5:15pm
8-K
n1u qeqtlyeo
12 Aug 19
Regulation FD Disclosure
8:16am